Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PeproStat in Intraoperative Surgical Haemostasis
NCT03131336Phase 2Completed
- Sponsor
- Haemostatix
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of PeproStat (2 arms), sponsored by Haemostatix. Primary endpoint: Time to Hemostasis at 10 minutes. Started Mar 2017; status: completed.
02
Drugs
PeproStat
Beyond the preview
Go deeper on NCT03131336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03131336.